Quantification of mutant KRASG12D and mutant p53 staining demonstrated cellular positivity rates in tumor of ∼70% and ∼40%, respectively; nontreated OCM pancreas had positivity rates close to zero (Fig. 3B). This evidence concerns the gene TP53 and neoplasm.